News | April 12, 2012

Maryland Law Requires Peer Review of Coronary Stents Implants

Cardiologists praise assembly because of help adhering to evidence-based medicine


April 12, 2012 — The Maryland General Assembly set a high bar for the nation and showed its commitment to patients by passing legislation establishing an independent review of the placement of stents in heart patients to ensure consistency with guidelines developed by the American College of Cardiology and other organizations, the Maryland Chapter of the American College of Cardiology said.

“An independent peer review process is critical to continuously assess patient safety and to ensure quality care for this essential, life-saving service,” said chapter President Marc Mugmon, M.D., FACC.

The Maryland Chapter of the American College of Cardiology proactively sought legislation last year to deal with the inconsistent utilization of peer review and its proposals were adopted as an amendment to HB 1141. The chapter was the catalyst in seeking enhanced independent, external peer review.

The Maryland chapter, at the invitation of the Maryland Health Care Commission, will be an integral part of the regulatory process to implement regulations and ongoing performance measures as a member of the newly established Clinical Advisory Group.

"The cardiovascular community, especially members of the American College of Cardiology, look forward to working with the Maryland Health Care Commission to develop regulations for peer review,” Mugmon said.

“The peer review component of the bill, which requires the development of minimum standards in the next year, will set a national precedent in cardiac care,” Mugmon said. “Peer review is a fundamental component of any comprehensive continuous quality improvement effort and will enhance patient safety by providing constructive, objective feedback to cardiologists in a collaborative environment.”

“Independent, external review will be free of bias and politics, and by identifying individual operator strengths and weaknesses, it will help achieve the highest standard of performance,” Mugmon said. “This process will complement robust internal programs and will rapidly identify and address potential deviations from accepted evidence-based guidelines for the use of stents.”

The Maryland Chapter, led by past-President Samuel Goldberg, M.D., FACC, and assisted by a team of clinical, interventional and academic cardiologists throughout the state, advocated for this legislation for the past two years.

“We are grateful that the Maryland Health Care Commission and the general assembly listened and finally understand the importance of this legislation to heart patients in Maryland,” Goldberg said. “We hope this will serve as a model for other states.”

The bill now goes to Governor Martin O’Malley for signature.

For more information: www.cardiosource.org/ACC


Related Content

News | Stents

April 17, 2024 — Getinge and Cook Medical announced an exclusive sales and distribution agreement for the iCast covered ...

Home April 17, 2024
Home
News | Stents

March 8, 2024 — Silk Road Medical, Inc., a company focused on reducing the risk of stroke and its devastating impact ...

Home March 08, 2024
Home
News | Stents

January 19, 2024 — W. L. Gore & Associates, Inc. announced that the first patients have been enrolled in the Gore VBX ...

Home January 19, 2024
Home
News | Stents

November 29, 2023 — InspireMD, Inc., developer of the CGuard Embolic Prevention Stent System (EPS) for the prevention of ...

Home November 29, 2023
Home
News | Stents

July 27, 2023 — Abiomed is recalling the Impella Intravascular Left Sided Blood Pumps because the pump’s Instructions ...

Home July 27, 2023
Home
News | Stents

June 13, 2023 — W. L. Gore & Associates (Gore) announced the initiation of the Gore VBX FORWARD Clinical Study ...

Home June 13, 2023
Home
News | Stents

March 5, 2023 — In patients with multi-vessel heart disease who have had a heart attack, immediate treatment with stents ...

Home March 05, 2023
Home
News | Stents

January 23, 2023 — A study of more than 100,000 patients has revealed that, for patients with blockages in multiple ...

Home January 23, 2023
Home
News | Stents

July 5, 2022 — A BIO-RESORT subgroup analysis of outcomes in small coronary vessels (<2,5mm) evaluated the efficacy and ...

Home July 05, 2022
Home
News | Stents

June 2, 2022 — According to the U.S. Food and Drug Administration (FDA), Atrium Medical Corporation is recalling the ...

Home June 02, 2022
Home
Subscribe Now